Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Diabetes

  Free Subscription


03.11.2025

1 Am J Manag Care
2 Biochem Biophys Res Commun
2 BMC Ophthalmol
1 BMC Pediatr
3 Diabet Med
1 Diabetes
5 Diabetes Care
11 Diabetes Obes Metab
5 Diabetologia
1 Invest Ophthalmol Vis Sci
1 J Clin Endocrinol Metab
1 J Diabetes Complications
1 J Nutr
3 JAMA
1 Kidney Int
4 N Engl J Med
1 Pediatr Diabetes
6 PLoS One
1 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Manag Care

  1. TURK MT, Ritchie ND, Norton B, Gallucci A, et al
    Opportunities and obstacles associated with the Medicare Diabetes Prevention Program.
    Am J Manag Care. 2025;31:578-582.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  2. HUANG KC, Lin CY, Chuang PY, Yang TY, et al
    Microbiota diversity and its influence on diabetic osteoporosis development.
    Biochem Biophys Res Commun. 2025;790:152884.
    PubMed         Abstract available

  3. NICESE MN, Koudijs A, Lalai R, Avramut C, et al
    Oral L-NAME supplementation accelerates the progression of kidney disease in diabetic mice.
    Biochem Biophys Res Commun. 2025;790:152859.
    PubMed         Abstract available


    BMC Ophthalmol

  4. ROOSTAEI S, Ashraf A, Fard MV, Johari M, et al
    Interrelationship of diabetic neuropathy, retinopathy and nephropathy in type 2 diabetes mellitus: a cross-sectional analysis.
    BMC Ophthalmol. 2025;25:604.
    PubMed         Abstract available

  5. SAEIDIAN J, Riazi-Esfahani H, Azimi H, Farrokhpour H, et al
    Automated FAZ segmentation and diabetic retinopathy classification using OCTA images.
    BMC Ophthalmol. 2025;25:602.
    PubMed         Abstract available


    BMC Pediatr

  6. CAO Y, Fan T, Lu R, Liu J, et al
    Effect of gestational diabetes on neurodevelopment outcome of the offsprings- Ma'an shan birth cohort study.
    BMC Pediatr. 2025;25:879.
    PubMed         Abstract available


    Diabet Med

  7. ELLIOTT J, Hopley C, Riley D, Dodd O, et al
    Assessment of the added value of a tubeless pump: A time trade-off (TTO) study for utility elicitation of insulin delivery systems in type 1 diabetes mellitus (T1D).
    Diabet Med. 2025 Oct 30:e70156. doi: 10.1111/dme.70156.
    PubMed         Abstract available

  8. WONG JJ, Alamarie SA, Hanes SJ, Flores H, et al
    An RCT of a family intervention for adolescents living with type 1 diabetes: Who benefits most?
    Diabet Med. 2025 Oct 29:e70151. doi: 10.1111/dme.70151.
    PubMed         Abstract available

  9. SUN W, Yang K, Wang B, Yang L, et al
    Forging a path forward in NARS2-related neonatal diabetes: A new horizon with artificial intelligence and digital health.
    Diabet Med. 2025 Oct 25:e70142. doi: 10.1111/dme.70142.
    PubMed        


    Diabetes

  10. GARG A, Xing C, Agarwal AK, Westfall AK, et al
    Erratum. Gain of Function NOTCH3 Variants Cause Familial Partial Lipodystrophy Due to Activation of Senescence Pathways. Diabetes 2025;74:427-438.
    Diabetes. 2025 Oct 28:db26er01a. doi: 10.2337.
    PubMed         Abstract available


    Diabetes Care

  11. FANG YE, Paik JM, Ortega-Montiel J, Tesfaye H, et al
    Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes.
    Diabetes Care. 2025 Oct 27:dc251840. doi: 10.2337/dc25-1840.
    PubMed         Abstract available

  12. CUI J, Liu Z, Tan WY, Chong JR, et al
    White Matter Hyperintensities Moderate the Association Between Diabetes and Non-AD Brain Atrophy.
    Diabetes Care. 2025 Oct 27:dc251162. doi: 10.2337/dc25-1162.
    PubMed         Abstract available

  13. SACRE JW, Wentworth JM, Magliano DJ, Shaw JE, et al
    Incidence of Type 2 Diabetes With Verapamil Compared With Other Calcium Channel Blockers.
    Diabetes Care. 2025 Oct 30:dc251440. doi: 10.2337/dc25-1440.
    PubMed         Abstract available

  14. GAO M, Saravanan S, Munyombwe T, Speight J, et al
    Effects of Modern Glucose Monitoring and Insulin Delivery Technologies on Patient-Reported Outcomes and Experiences in Individuals With Type 1 Diabetes: A Systematic Review and Meta-analysis.
    Diabetes Care. 2025 Oct 30:dc251178. doi: 10.2337/dc25-1178.
    PubMed         Abstract available

  15. POP-BUSUI R, Repetto E, Baron J, Schumacher D, et al
    Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure.
    Diabetes Care. 2025 Oct 30:dc251260. doi: 10.2337/dc25-1260.
    PubMed         Abstract available


    Diabetes Obes Metab

  16. PASQUA MR, Tsoukas MA, Haidar A
    Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post-hoc analysis of a double-blinded, randomised, crossover trial.
    Diabetes Obes Metab. 2025 Oct 27. doi: 10.1111/dom.70213.
    PubMed         Abstract available

  17. LAN H, Xu S, Li H, Guo R, et al
    Plasma proteomics identifies potential drug targets for diabetic polyneuropathy: Evidence from prospective cohorts and genetic analysis.
    Diabetes Obes Metab. 2025 Oct 27. doi: 10.1111/dom.70239.
    PubMed         Abstract available

  18. CHAUDHRY A, Thompson DM, Chanoine JP
    Diabetes management in maternally inherited diabetes and deafness (MIDD): A review and a proposed treatment algorithm.
    Diabetes Obes Metab. 2025 Oct 27. doi: 10.1111/dom.70240.
    PubMed         Abstract available

  19. YANG W, Cai X, Ji Q, Tong N, et al
    Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023-2024.
    Diabetes Obes Metab. 2025 Oct 27. doi: 10.1111/dom.70222.
    PubMed         Abstract available

  20. LIN R, Hsu CL, Shih MC, Chien KL, et al
    Comparison of the renal outcomes of novel antidiabetic agents in patients with type 2 diabetes with chronic kidney disease: A systematic review and network meta-analysis of randomized controlled trials.
    Diabetes Obes Metab. 2025 Oct 28. doi: 10.1111/dom.70224.
    PubMed         Abstract available

  21. MEFFEN A, Tyrer F, Mbah Mbahnjeck J, Khunti K, et al
    Blood pressure and adverse cardiovascular outcomes in older people with type 2 diabetes and chronic kidney disease: Findings based on the Clinical Practice Research Datalink databases in England.
    Diabetes Obes Metab. 2025 Oct 28. doi: 10.1111/dom.70234.
    PubMed         Abstract available

  22. GOLDENBERG RM
    An indirect treatment comparison of tirzepatide 10 and 15 mg versus high-dose semaglutide 7.2 mg in people with obesity and type 2 diabetes.
    Diabetes Obes Metab. 2025 Oct 29. doi: 10.1111/dom.70253.
    PubMed        

  23. GLATZ U, Muller A, Moser O, Aberer F, et al
    Acute and prolonged effects of aerobic endurance training on N-lactoyl-phenylalanine and inflammatory markers in individuals with type 1 diabetes: An exploratory analysis of the ULTRAFLEXI-1 study.
    Diabetes Obes Metab. 2025 Oct 29. doi: 10.1111/dom.70236.
    PubMed        

  24. BOWE A, Hayes M, John I, Diaz M, et al
    Glucagon-like peptide-1 receptor agonist versus sodium-glucose cotransporter-2 inhibitor persistence in Medicare Advantage beneficiaries with type 2 diabetes, cardiovascular risk, and obesity.
    Diabetes Obes Metab. 2025 Oct 30. doi: 10.1111/dom.70219.
    PubMed         Abstract available

  25. YONEDA M, Takeuchi M, Oura T, Nakajima A, et al
    Decreased fatty liver index with tirzepatide treatment in Japanese patients with type 2 diabetes: A SURPASS J-mono post hoc analysis.
    Diabetes Obes Metab. 2025 Oct 27. doi: 10.1111/dom.70225.
    PubMed        

  26. DE MEULEMEESTER J, Valgaerts L, Tenoutasse S, Gies I, et al
    One-year effectiveness and safety in young children aged 2-6 years with type 1 diabetes using an automated insulin delivery system: A real-world prospective cohort study.
    Diabetes Obes Metab. 2025 Oct 27. doi: 10.1111/dom.70228.
    PubMed         Abstract available


    Diabetologia

  27. TOKORO MF, Mita T, Osonoi Y, Someya Y, et al
    An evening chronotype is associated with the incidence and progression of diabetic retinopathy in people with type 2 diabetes mellitus: a cohort study.
    Diabetologia. 2025 Oct 24. doi: 10.1007/s00125-025-06590.
    PubMed         Abstract available

  28. WANG S, Jia X, Yin Y, Lin H, et al
    Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study. Reply to Liu W, Deng B [letter].
    Diabetologia. 2025 Oct 29. doi: 10.1007/s00125-025-06589.
    PubMed        

  29. LIU W, Deng B
    Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study.
    Diabetologia. 2025 Oct 30. doi: 10.1007/s00125-025-06588.
    PubMed        

  30. STIMSON RH, Dover AR, Clarke C, Conceicao C, et al
    Persistent C-peptide secretion is associated with favourable CGM metrics in adults with type 1 diabetes.
    Diabetologia. 2025 Oct 30. doi: 10.1007/s00125-025-06578.
    PubMed         Abstract available

  31. BAILEY CJ
    Pharmacological therapies for type 2 diabetes: future approaches.
    Diabetologia. 2025 Oct 31. doi: 10.1007/s00125-025-06581.
    PubMed         Abstract available


    Invest Ophthalmol Vis Sci

  32. SHAH J, Zhuang K, Kakihara S, Fawzi AA, et al
    Understanding How Low Luminance Visual Deficit Progresses With Advancing Diabetic Macular Ischemia and Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:38.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  33. KONTOLA H, Crisostomo L, Loyttyniemi E, Koskenniemi JJ, et al
    Altered Glucagon Response to Oral Glucose in Individuals at Different Stages of Type 1 Diabetes Development.
    J Clin Endocrinol Metab. 2025 Oct 31:dgaf601. doi: 10.1210.
    PubMed         Abstract available


    J Diabetes Complications

  34. CANGELOSI G, Sacchini F, Mancin S, Morales Palomares S, et al
    Response to: "Letter to the editor "The role of artificial intelligence in diabetic retinopathy screening in type 1 diabetes: A systematic review".
    J Diabetes Complications. 2025 Oct 6:109180. doi: 10.1016/j.jdiacomp.2025.109180
    PubMed        


    J Nutr

  35. RAWAL A, Maindal HT, Dahl-Petersen IK, Jensen DM, et al
    Dietary changes and their predictors in the first year after childbirth in women with gestational diabetes mellitus: A post-hoc longitudinal analysis from the Face-it trial.
    J Nutr. 2025 Oct 23:S0022-3166(25)00647-9. doi: 10.1016/j.tjnut.2025.
    PubMed         Abstract available


    JAMA

  36. DONOVAN LE, Lemieux P, Dunlop AD, Yamamoto JM, et al
    Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy: The CIRCUIT Randomized Clinical Trial.
    JAMA. 2025 Oct 24:e2519578. doi: 10.1001/jama.2025.19578.
    PubMed         Abstract available

  37. MATHIOUDAKIS N, Lalani B, Abusamaan MS, Alderfer M, et al
    An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial.
    JAMA. 2025 Oct 27:e2519563. doi: 10.1001/jama.2025.19563.
    PubMed         Abstract available

  38. PERREAULT L
    Artificial Intelligence and Diabetes Prevention.
    JAMA. 2025 Oct 27. doi: 10.1001/jama.2025.20099.
    PubMed        


    Kidney Int

  39. LI X, He JC, Lee K
    New potential therapeutic targets of metabolic disorder-associated kidney disease and diabetic kidney disease.
    Kidney Int. 2025 Oct 23:S0085-2538(25)00838-5. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available


    N Engl J Med

  40. ASSIL R, Hough A
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2025;393:1753-1754.
    PubMed        

  41. SILVER S
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2025;393:1754.
    PubMed        

  42. ROMAGNANI P, Soler MJ, Fervenza FC
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2025;393:1754.
    PubMed        

  43. AGARWAL R, Rossing P, Mann JFE
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. Reply.
    N Engl J Med. 2025;393:1755.
    PubMed        


    Pediatr Diabetes

  44. SRACIC K, Uli N, Heksch R
    Change in Age of Diagnosis and Demographics of Type 1 Diabetes Mellitus During the COVID-19 Era.
    Pediatr Diabetes. 2025;2025:7276579.
    PubMed         Abstract available


    PLoS One

  45. GYOUTOKU N, Inoguchi Y, Rikitake J, Demiya M, et al
    Effect of imeglimin on metabolic dysfunction-associated steatotic liver disease in individuals with type 2 diabetes.
    PLoS One. 2025;20:e0335888.
    PubMed         Abstract available

  46. ZARTAB S, Abbasian H
    Antidiabetic drug utilization pattern, affordability and cost analysis in Iran from 2009 to 2021: A need to revise guideline.
    PLoS One. 2025;20:e0333186.
    PubMed         Abstract available

  47. ALJOHANI N, Forbes A, Daqrashawi G, Due-Christensen M, et al
    'You decided I am old enough for the transition, but not old enough to have a say?': Exploring young people's, parents', and healthcare providers' views and experiences of Type 1 Diabetes paediatric to adult healthcare transition in Saudi Arabia.
    PLoS One. 2025;20:e0335347.
    PubMed         Abstract available

  48. NUM KSF, Aizuddin AN, Hashim SM, Said MSM, et al
    Navigating interprofessional collaboration in diabetes care: A qualitative study of early-career health professionals in malaysian primary care clinics.
    PLoS One. 2025;20:e0335192.
    PubMed         Abstract available

  49. ZGLEJC-WASZAK K, Jastrzebski JP, Wojtkiewicz J, Pidsudko Z, et al
    Novel insights into neuropathy: The impact of prolonged hyperglycemia on long non-coding RNA expression.
    PLoS One. 2025;20:e0334245.
    PubMed         Abstract available

  50. LI J, Zhang H, Duan X, Zhang M, et al
    Comprehensive analysis of cuproptosis-related genes in diabetic cardiomyopathy.
    PLoS One. 2025;20:e0328512.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  51. SHEN W, Nie Z, Wang M, Zhang H, et al
    Monocyte-derived exosomal periostin driven by histone lactylation contributes to retinal neovascularization.
    Proc Natl Acad Sci U S A. 2025;122:e2501704122.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.